Best Peptide Protocols
    Cognitive / NeurologicalSingle

    B7-33 5mg: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for B7-33 (5 mg Vial).

    Strength & Form:5 mg Vial
    B7-33 (5 mg Vial) peptide vial

    B7-33 (5 mg Vial)

    5 mg Research Peptide

    Quick Facts

    Type
    Single
    Category
    Cognitive / Neurological
    Vial Strength
    5 mg
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete B7-33 5mg research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is B7-33 5mg?

    B7-33 5mg Vial Overview

    B7-33 is a single-chain peptide analog of the hormone relaxin-2 that selectively activates the RXFP1 receptor. Unlike native relaxin, B7-33 is simpler to synthesize and more stable. Research shows it promotes anti-fibrotic effects, vasodilation, and tissue remodeling. It is being investigated for neurological applications due to RXFP1 receptor expression in the brain.

    B7-33 5mg Quick Reference

    B7-33 5mg Vial Specifications

    Peptide
    B7-33 (5 mg Vial) (NNMT inhibitor)
    Vial Content
    5 mg total peptide
    Category
    Cognitive / Neurological
    Administration Method
    Subcutaneous injection
    Common Use Case
    Anti-fibrotic research and cardiovascular support

    B7-33 5mg Compared With Other Formats

    Details that distinguish this 5 mg format include:

    • Simplified relaxin-2 analog with improved stability
    • Selective RXFP1 receptor activation
    • Anti-fibrotic properties without full relaxin side effects

    How Does B7-33 Work?

    B7-33 Mechanism of Action

    B7-33 is a single-chain peptide that selectively activates the RXFP1 (relaxin family peptide receptor 1) with biased agonism favoring anti-fibrotic signaling pathways. It reduces collagen deposition, inhibits myofibroblast differentiation, and promotes extracellular matrix remodeling. Unlike full-length relaxin, B7-33 is easier to synthesize and may have improved tissue selectivity.

    What Are the Potential Benefits of B7-33?

    B7-33 Research Findings and Observed Outcomes

    Findings and reported areas of study for B7-33 (5 mg Vial) include:

    • Anti-fibrotic tissue remodeling
    • Vasodilation and improved blood flow
    • Reduced pathological collagen deposition
    • Simplified synthesis vs native relaxin

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute B7-33 5mg?

    B7-33 5mg Supplies for Reconstitution and Handling

    • •Insulin syringes (29–31 gauge)
    • •Bacteriostatic water
    • •Alcohol prep pads
    • •Sharps container

    Supplies listed are for laboratory handling and research preparation purposes only.

    B7-33 5mg Administration and Research Protocol

    B7-33 Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    FrequencyOnce daily
    TimingConsistent timing preferred

    B7-33 5mg Dosage Guide

    B7-33 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range50 mcg per day
    Standard Range100 mcg per day
    Upper Range250 mcg per day

    B7-33 5mg Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    50 mcg0.02 mL2 units
    100 mcg0.04 mL4 units
    250 mcg0.10 mL10 units

    This dosing table is unique to the 5 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a B7-33 5mg Vial Last?

    B7-33 5mg Duration by Research Dose

    At common research doses, one 5 mg vial of B7-33 typically supports:

    50 mcg per day~100 days
    100 mcg per day~50 days
    250 mcg per day~20 days

    Extended protocols for fibrotic conditions.

    How to Reconstitute B7-33 5mg

    B7-33 5mg Reconstitution With Bacteriostatic Water

    This section applies specifically to the B7-33 (5 mg Vial).

    Recommended Diluent
    Bacteriostatic water
    Diluent Volume
    2 mL
    Final Concentration
    2.5 mg/mL

    B7-33 5mg Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    B7-33 Stacks and Research Combinations

    B7-33 and Compatible Research Pairings

    In research settings, B7-33 (5 mg Vial) is sometimes paired with peptides such as:

    • BPC-157: Complementary tissue repair and remodeling

    Factors That May Affect B7-33 Research Outcomes

    Supporting Factors for B7-33 Research

    Factors recorded alongside this protocol include:

    • Anti-inflammatory diet
    • Regular gentle exercise
    • Stress management
    • Adequate hydration

    These factors can affect how research observations are interpreted.

    B7-33 Side Effects and Safety Considerations

    B7-33 5mg Tolerability Notes

    Limited human data. Generally well-tolerated in preclinical studies.

    Some individuals report:

    • Injection site reactions
    • Possible blood pressure changes
    • Mild headache

    How to Store B7-33 Before and After Reconstitution

    B7-33 5mg Storage Requirements

    Unreconstituted
    Store frozen at −20°C
    Reconstituted
    Refrigerate at 2–8°C
    Post-Mix Stability
    Up to 3–4 weeks

    Who Should Avoid B7-33?

    This peptide is generally not recommended for:

    • Pregnant or breastfeeding individuals
    • Those with hypotension
    • Anyone advised otherwise by a healthcare professional

    B7-33 5mg FAQs

    What's the difference between B7-33 and relaxin?

    B7-33 is a simplified single-chain analog that selectively activates RXFP1 for anti-fibrotic effects, whereas native relaxin is a two-chain peptide with broader physiological effects.

    Where to Buy B7-33 5mg for Research

    B7-33 5mg Purchasing and Research Supply Notes

    Before ordering B7-33 (5 mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Cognitive / Neurological Peptides

    Adamax (10 mg Vial) productAdamax (10 mg Vial)DSIP (5 mg Vial) productDSIP (5 mg Vial)N-Acetyl Selank Amidate (12.5 mg Vial) productN-Acetyl Selank Amidate (12.5 mg Vial)N-Acetyl Semax Amidate (30 mg Vial) productN-Acetyl Semax Amidate (30 mg Vial)P21 (10 mg Vial) productP21 (10 mg Vial)PE 22-28 (8 mg Vial) productPE 22-28 (8 mg Vial)